Core Viewpoint - Suzhou Lianxun Instrument Co., Ltd. is set to become the first company to undergo the IPO review for the Sci-Tech Innovation Board in 2026, with the meeting scheduled for January 14, 2026. The company has shown steady annual performance growth and is expected to turn a profit in 2024, despite significant increases in accounts receivable and inventory during the reporting period [1][4][6]. Group 1: IPO and Fundraising - Lianxun Instrument's IPO application was accepted on August 15, 2025, and it entered the inquiry phase on August 28, 2025 [4]. - The initial fundraising target was set at 19.54 billion yuan, which has been reduced to 17.11 billion yuan following adjustments to the investment projects [5]. - The company has canceled the initial plans for the construction of a research and manufacturing center and the replenishment of working capital, instead adding a new project for the development of next-generation testing instruments [5]. Group 2: Financial Performance - The company reported revenues of approximately 214 million yuan, 276 million yuan, and 789 million yuan for the years 2022, 2023, and 2024, respectively, with a projected revenue of 1.15 to 1.2 billion yuan for 2025, representing a year-on-year growth of 45.82% to 52.16% [6][8]. - The net profit attributable to shareholders is expected to be between 145 million yuan and 165 million yuan for 2025, showing a year-on-year increase of 3.21% to 17.44% [6]. - The company’s overseas business revenue has significantly increased, with a rise of nearly 20 percentage points in the proportion of overseas revenue to total revenue during the first three quarters of 2025 [6][7]. Group 3: Financial Health Indicators - The company’s cash flow from operating activities was negative at -25.48 million yuan for the first three quarters of 2025, compared to a positive cash flow of 80.79 million yuan in 2024 [8]. - The asset-liability ratio has been increasing, recorded at 26.71%, 41.08%, 47.66%, and 49.74% over the reporting periods [8]. - Accounts receivable and inventory balances have also seen significant increases, with accounts receivable reaching 400 million yuan and inventory at 474 million yuan by the end of the reporting period [8].

Core Viewpoint - The article discusses the upcoming IPO of Suzhou Lianxun Instrument Co., Ltd., which aims to raise approximately 1.711 billion yuan for various R&D projects in electronic measurement and semiconductor testing equipment [1]. Group 1: IPO Details - Lianxun Instrument plans to raise around 1.711 billion yuan through its IPO, with specific allocations for projects including 513 million yuan for next-generation optical communication testing equipment, 199 million yuan for automotive chip testing equipment, 385 million yuan for storage testing equipment, 304 million yuan for digital testing instruments, and 310 million yuan for the construction of a next-generation testing instrument R&D center [1]. - The company was established in 2017 with a registered capital of 77 million yuan, focusing on the R&D, manufacturing, sales, and service of electronic measurement instruments and semiconductor testing equipment [1]. Group 2: Company Background - The founder of Lianxun Instrument, Hu Haiyang, has a Ph.D. and extensive experience in the electronic measurement and semiconductor testing equipment industry, having worked for 15 years at Keysight Technologies, which originated from HP's electronic measurement division [2]. - Hu Haiyang transitioned to a marketing role at a newly established company before founding Lianxun Instrument, where he initially held a 55% stake through a proxy [2].